Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

1134620 records

$47,250.00

Jan 21, 2021
Agreement:

217926

Agreement Number:

217926

Duration: from Jan 21, 2021 to Mar 31, 2021
Description:

Engage expertise in the area of digital adoption

Organization: Atlantic Canada Opportunities Agency
Program Name: REGI - Digital Acceleration Pilot
Location: Charlottetown, Prince Edward Island, CA C1E 2B4

$15,000.00

Jan 21, 2021
Agreement:

217928

Agreement Number:

217928

Duration: from Jan 21, 2021 to Mar 31, 2021
Description:

Engage expertise in the area of digital adoption

Organization: Atlantic Canada Opportunities Agency
Program Name: REGI - Digital Acceleration Pilot
Location: Spring Valley, Prince Edward Island, CA C0B 1M0

$76,610.00

Jan 21, 2021
Agreement:

217790

Agreement Number:

217790

Duration: from Jan 21, 2021 to Mar 31, 2021
Description:

Provide assistance to mitigate impacts of Covid-19

Organization: Atlantic Canada Opportunities Agency
Program Name: REGI - Business Scale-up and Productivity
Location: Dartmouth, Nova Scotia, CA B3B 1S1

$279,408.00

Jan 21, 2021

For-profit organization

Agreement:

Sensor integration on a Canadian coast guard vessel to assist in characterization of the ice environment

Agreement Number:

964449

Duration: from Jan 21, 2021 to Sep 30, 2022
Description:

The collaborative research Project develops a scientific research methodology to deploy sensors aboard an ice-going ship (Canadian Coast Guard Icebreaker CCGS Henry Larsen) in order to measure ice severity. Ice severity is related to a number of physical properties of ice, including: ice strength, ice thickness, ice age, ice coverage, ice piece size, pressure within the ice pack, etc. There is a significant body of scientific knowledge related to measuring certain ice properties from a ship but there are significant gaps in this knowledge. One of the main research gaps is that previous research has focused on measuring a specific ice property. However, no methods currently exist in the scientific literature for a holistic measurement of ice severity. The collaborative research Project addresses the research gap by using advanced scientific sensors to measure the impact of ice severity on a sea vessel traveling in Canadian icy waters.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: St. John's, Newfoundland & Labrador, CA A1B 3X5

$303,341.00

Jan 21, 2021

Academia

Agreement:

Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines

Agreement Number:

964417

Duration: from Jan 21, 2021 to Mar 31, 2022
Description:

The University of Guelph developed a vaccine to protect against the novel coronavirus disease that emerged in 2019 (COVID-19) using a safe vector known as avian orthoavulavirus-1 (AOaV-1) with a transgene encoding the full-length spike protein (FLS) from severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). In a hamster challenge model of COVID-19, intranasal vaccination with AOaV-1-FLS completely protected against disease, and SARS-CoV-2 could not be detected. This correlated with the induction of a SARS-CoV-2-specific immune responses in the lungs. The next step requires that this vaccine be optimized for administration into the respiratory system of humans. Specifically, the vaccine vector needs to be adapted to function across a broad range of temperatures, including the relatively low temperature of the nasal passages and the higher temperatures in the lungs. Also, intranasal versus aerosol delivery into the respiratory system will be tested to determine if nasal and/or respiratory delivery induces protective immune responses. In parallel, a next-generation version of the vaccine that expresses a prefusion stabilized SARS-CoV-2 spike protein will be engineered and tested in mice and hamster COVID-19 challenge models. This research will pave the way toward a human clinical trial.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Guelph, Ontario, CA N1G 2W1

$303,341.00

Jan 21, 2021

Academia

Agreement:

Newcastle Disease Virus (NDV) as a novel platform for development of COVID-19 vaccines

Agreement Number:

964417

Duration: from Jan 21, 2021 to Jan 17, 2022
Description:

The University of Guelph developed a vaccine to protect against the novel coronavirus disease that emerged in 2019 (COVID-19) using a safe vector known as avian orthoavulavirus-1 (AOaV-1) with a transgene encoding the full-length spike protein (FLS) from severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). In a hamster challenge model of COVID-19, intranasal vaccination with AOaV-1-FLS completely protected against disease, and SARS-CoV-2 could not be detected. This correlated with the induction of a SARS-CoV-2-specific immune responses in the lungs. The next step requires that this vaccine be optimized for administration into the respiratory system of humans. Specifically, the vaccine vector needs to be adapted to function across a broad range of temperatures, including the relatively low temperature of the nasal passages and the higher temperatures in the lungs. Also, intranasal versus aerosol delivery into the respiratory system will be tested to determine if nasal and/or respiratory delivery induces protective immune responses. In parallel, a next-generation version of the vaccine that expresses a prefusion stabilized SARS-CoV-2 spike protein will be engineered and tested in mice and hamster COVID-19 challenge models. This research will pave the way toward a human clinical trial.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Guelph, Ontario, CA N1G 2W1

$279,408.00

Jan 21, 2021

For-profit organization

Agreement:

Sensor integration on a Canadian coast guard vessel to assist in characterization of the ice environment

Agreement Number:

964449

Duration: from Jan 21, 2021 to May 31, 2021
Description:

The collaborative research Project develops a scientific research methodology to deploy sensors aboard an ice-going ship (Canadian Coast Guard Icebreaker CCGS Henry Larsen) in order to measure ice severity. Ice severity is related to a number of physical properties of ice, including: ice strength, ice thickness, ice age, ice coverage, ice piece size, pressure within the ice pack, etc. There is a significant body of scientific knowledge related to measuring certain ice properties from a ship but there are significant gaps in this knowledge. One of the main research gaps is that previous research has focused on measuring a specific ice property. However, no methods currently exist in the scientific literature for a holistic measurement of ice severity. The collaborative research Project addresses the research gap by using advanced scientific sensors to measure the impact of ice severity on a sea vessel traveling in Canadian icy waters.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: St John's, Newfoundland & Labrador, CA A1B 3X5

$1,244,000.00

Jan 21, 2021
Description:

Conserving and enhancing species at risk habitat in Alberta grasslands: collaboration between Canadian Cattlemen’s Association, Alberta Beef Producers, Multiple Species at Risk (MULTISAR) and Cows and Fish

Organization: Environment and Climate Change Canada
Location: Calgary, Alberta, CA
Description:

Action plan implementation for areas of interest from the Atlas for Conservation in the St. Lawrence Lowlands within the Centre-du-Québec region

Organization: Environment and Climate Change Canada
Location: Drummondville, Quebec, CA
Description:

WaterPhyt: Environmental Protection by Sustainable Wastewater Phytofiltration

Organization: Environment and Climate Change Canada
Location: Montreal, Quebec, CA